Mangalam Drugs & Organics Limited (BOM:532637)

Market Cap	464.08M -55.6%
Revenue (ttm)	2.62B -22.2%
Net Income	-381.02M
EPS	-24.07
Shares Out	15.83M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,541
Open	30.60
Previous Close	30.45
Day's Range	28.20 - 30.60
52-Week Range	22.70 - 66.04
Beta	0.31
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Mangalam Drugs & Organics

Mangalam Drugs & Organics Limited, together with its subsidiary, manufactures and sells active pharmaceutical ingredients (APIs) and intermediates in India. The company offers active pharmaceutical ingredients (API) products, including acyclovir, amodiaquine, artemether, artesunate, bisoprolol fumarate, chloroquine phosphate, dihydroartemisinin, dolutegravir sodium, efavirenz, emtricitabine, etodolac, furosemide, hydroxychloroquine sulphate, lumefantrine, nimesulide, nitrofurantoin anhydrous and monohydrate, olanzapine, primaquine and piperaqui...

• Industry: Pharmaceutical Preparations
• Founded: 1972
• Employees: 319
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 532637

Financial Performance

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 6, 2026

Data Sources Report a data error